NEOG — Neogen Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapContrarian

Annual income statement for Neogen, fiscal year end - May 31st, USD millions except per share, conversion factor applied.

	2020 May 31st	2021 May 31st	2022 May 31st	2023 May 31st	2024 May 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	418	468	527	822	924
Cost of Revenue
Gross Profit	196	215	243	406	464
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	351	394	469	785	866
Operating Profit	67.5	74.2	58.6	37.5	58.7
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	72.3	75.3	60.2	-22	-14.3
Provision for Income Taxes
Net Income After Taxes	59.5	60.9	48.3	-22.9	-9.42
Minority Interest
Net Income Before Extraordinary Items
Net Income	59.5	60.9	48.3	-22.9	-9.42
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	59.5	60.9	48.3	-22.9	-9.42
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.563	0.568	0.447	0.115	0.039